{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:40:32Z","timestamp":1794807632874,"version":"4.9.1"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["184.034.019"],"award-info":[{"award-number":["184.034.019"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NWO Zwaartekracht program"},{"DOI":"10.13039\/501100003000","name":"Stichting MS Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Multiple sclerosis (MS) is a chronic neuroinflammatory disease in which demyelinating white matter lesions accumulate and expand, driving irreversible disability. Here we identify a distinct population of foamy GPNMB\n                    <jats:sup>+<\/jats:sup>\n                    microglia\/macrophages associated with lesion expansion in secondary progressive MS. Using integrated lipidomic, transcriptomic, proteomic, chemical proteomic and histological analyses of human postmortem MS lesions, we show that lesions containing foamy microglia\/macrophages exhibit disrupted lipid metabolism, lysosomal stress and markers associated with heightened phagocytosis and antigen presentation without classical pro-inflammatory signatures. These lesions are enriched for oxylipins, bismonoacylglycerolphosphates and cholesterol esters, and are associated with increased B cell infiltration and IgG1. Monoacylglycerol lipase (MAGL), a lipid-metabolizing enzyme enriched in lesions with foamy microglia\/macrophages, emerged as a potential therapeutic target. Inhibition of MAGL promoted lesion recovery and reduced microgliosis in a mouse model of demyelination. Finally, oxylipins in cerebrospinal fluid correlate with the proportion of foamy lesions, suggesting potential biomarkers for progression. Our findings implicate disturbed lipid metabolism in chronic MS pathology and suggest that foamy microglia\/macrophages are an interesting cell type to target for progressive disease.\n                  <\/jats:p>","DOI":"10.1038\/s41593-026-02302-3","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:02:05Z","timestamp":1779354125000},"page":"1585-1598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Foamy microglia link oxylipins to disease progression in multiple sclerosis"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7317-9679","authenticated-orcid":false,"given":"Daan","family":"van der Vliet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4191-6061","authenticated-orcid":false,"given":"Tatiana M.","family":"Shamorkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Coulon-Bainier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anto","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris A. C. M.","family":"van der Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8273-9699","authenticated-orcid":false,"given":"Yingyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6357-0834","authenticated-orcid":false,"given":"Will","family":"Macnair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"van Egmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Q. Alida","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8886-8928","authenticated-orcid":false,"given":"Aletta M. R.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik J.","family":"Engelenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0801-4453","authenticated-orcid":false,"given":"Dennis","family":"Wever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R. J.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9250-0381","authenticated-orcid":false,"given":"Wouter P. F.","family":"Driever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Gagestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Dusseldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-9270","authenticated-orcid":false,"given":"Uwe","family":"Grether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Netherlands Brain Bank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta M. R.","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon","family":"de Goeij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J. M.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2931-4295","authenticated-orcid":false,"given":"Amy C.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7871-2073","authenticated-orcid":false,"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2405-4404","authenticated-orcid":false,"given":"Albert J. R.","family":"Heck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-8920","authenticated-orcid":false,"given":"Inge","family":"Huitinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1029-5717","authenticated-orcid":false,"given":"Mario","family":"van der Stelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2302_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann, T. et al. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 133, 13\u201324 (2017).","journal-title":"Acta Neuropathol."},{"key":"2302_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Primers 4, 43 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2302_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann, T. et al. Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol. 22, 78\u201388 (2023).","journal-title":"Lancet Neurol."},{"key":"2302_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02742-w","volume":"147","author":"A De Boer","year":"2024","unstructured":"De Boer, A. et al. Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions. Acta Neuropathol. 147, 90 (2024).","journal-title":"Acta Neuropathol."},{"key":"2302_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/bpa.12760","volume":"30","author":"NL Fransen","year":"2020","unstructured":"Fransen, N. L. et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 30, 106\u2013119 (2020).","journal-title":"Brain Pathol."},{"key":"2302_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","volume":"135","author":"S Luchetti","year":"2018","unstructured":"Luchetti, S. et al. Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis. Acta Neuropathol. 135, 511\u2013528 (2018).","journal-title":"Acta Neuropathol."},{"key":"2302_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.24497","volume":"78","author":"JM Frischer","year":"2015","unstructured":"Frischer, J. M. et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque: dynamic nature of MS plaque. Ann. Neurol. 78, 710\u2013721 (2015).","journal-title":"Ann. Neurol."},{"key":"2302_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-020-02189-9","volume":"140","author":"K He\u00df","year":"2020","unstructured":"He\u00df, K. et al. Lesion stage-dependent causes for impaired remyelination in MS. Acta Neuropathol. 140, 359\u2013375 (2020).","journal-title":"Acta Neuropathol."},{"key":"2302_CR9","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181a8260a","volume":"72","author":"T Goldschmidt","year":"2009","unstructured":"Goldschmidt, T., Antel, J., Konig, F. B., Bruck, W. & Kuhlmann, T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 72, 1914\u20131921 (2009).","journal-title":"Neurology"},{"key":"2302_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1126\/science.aan4183","volume":"359","author":"L Cantuti-Castelvetri","year":"2018","unstructured":"Cantuti-Castelvetri, L. et al. Defective cholesterol clearance limits remyelination in the aged central nervous system. Science 359, 684\u2013688 (2018).","journal-title":"Science"},{"key":"2302_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta, M. et al. A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis. Nature 597, 709\u2013714 (2021).","journal-title":"Nature"},{"key":"2302_CR12","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1172\/JCI86198","volume":"126","author":"M Absinta","year":"2016","unstructured":"Absinta, M. et al. Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J. Clin. Invest. 126, 2597\u20132609 (2016).","journal-title":"J. Clin. Invest."},{"key":"2302_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-016-1636-z","volume":"133","author":"A Dal-Bianco","year":"2017","unstructured":"Dal-Bianco, A. et al. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7T magnetic resonance imaging. Acta Neuropathol. 133, 25\u201342 (2017).","journal-title":"Acta Neuropathol."},{"key":"2302_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/brain\/awh707","volume":"129","author":"LA Boven","year":"2006","unstructured":"Boven, L. A. et al. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 129, 517\u2013526 (2006).","journal-title":"Brain"},{"key":"2302_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0628-8","volume":"6","author":"E Grajchen","year":"2018","unstructured":"Grajchen, E., Hendriks, J. J. A. & Bogie, J. F. J. The physiology of foamy phagocytes in multiple sclerosis. Acta Neuropathol. Commun. 6, 124 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"2302_CR16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191660","volume":"217","author":"JFJ Bogie","year":"2020","unstructured":"Bogie, J. F. J. et al. Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain. J. Exp. Med. 217, e20191660 (2020).","journal-title":"J. Exp. Med."},{"key":"2302_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jneuroim.2017.04.007","volume":"309","author":"DAE Hendrickx","year":"2017","unstructured":"Hendrickx, D. A. E., van Eden, C. G., Schuurman, K. G., Hamann, J. & Huitinga, I. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. J. Neuroimmunol. 309, 12\u201322 (2017).","journal-title":"J. Neuroimmunol."},{"key":"2302_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084039","volume":"22","author":"M Van Eijk","year":"2021","unstructured":"Van Eijk, M. & Aerts, J. M. F. G. The unique phenotype of lipid-laden macrophages. Int. J. Mol. Sci. 22, 4039 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2302_CR19","doi-asserted-by":"publisher","first-page":"e1154","DOI":"10.1212\/NXI.0000000000001154","volume":"9","author":"A Van den Bosch","year":"2022","unstructured":"Van den Bosch, A. et al. Neurofilament light chain levels in multiple sclerosis correlate with lesions containing foamy macrophages and with acute axonal damage. Neurol. Neuroimmunol. Neuroinflamm. 9, e1154 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"2302_CR20","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.bbalip.2014.12.016","volume":"1851","author":"S Schmitt","year":"2015","unstructured":"Schmitt, S., Cantuti Castelvetri, L. & Simons, M. Metabolism and functions of lipids in myelin. Biochim. Biophys. Acta 1851, 999\u20131005 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"2302_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fncel.2020.00238","volume":"14","author":"S J\u00e4kel","year":"2020","unstructured":"J\u00e4kel, S. & Williams, A. What have advances in transcriptomic technologies taught us about human white matter pathologies? Front. Cell. Neurosci. 14, 238 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"2302_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","volume":"573","author":"L Schirmer","year":"2019","unstructured":"Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75\u201382 (2019).","journal-title":"Nature"},{"key":"2302_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","volume":"566","author":"S J\u00e4kel","year":"2019","unstructured":"J\u00e4kel, S. et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566, 543\u2013547 (2019).","journal-title":"Nature"},{"key":"2302_CR24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuron.2024.11.016","volume":"113","author":"W Macnair","year":"2025","unstructured":"Macnair, W. et al. snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses. Neuron 113, 396\u2013410 (2025).","journal-title":"Neuron"},{"key":"2302_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01810","volume":"8","author":"DAE Hendrickx","year":"2017","unstructured":"Hendrickx, D. A. E. et al. Gene expression profiling of multiple sclerosis pathology identifies early patterns of demyelination surrounding chronic active lesions. Front. Immunol. 8, 1810 (2017).","journal-title":"Front. Immunol."},{"key":"2302_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0855-7","volume":"7","author":"ML Elkjaer","year":"2019","unstructured":"Elkjaer, M. L. et al. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis. Acta Neuropathol. Commun. 7, 205 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"2302_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200219","volume":"11","author":"DC Ladakis","year":"2024","unstructured":"Ladakis, D. C. et al. Metabolomics of multiple sclerosis lesions demonstrates lipid changes linked to alterations in transcriptomics-based cellular profiles. Neurol. Neuroimmunol. Neuroinflamm. 11, e200219 (2024).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"2302_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","volume":"24","author":"SA Berghoff","year":"2021","unstructured":"Berghoff, S. A. et al. Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat. Neurosci. 24, 47\u201360 (2021).","journal-title":"Nat. Neurosci."},{"key":"2302_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41593-021-00801-z","volume":"24","author":"Y Dong","year":"2021","unstructured":"Dong, Y. et al. Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. Nat. Neurosci. 24, 489\u2013503 (2021).","journal-title":"Nat. Neurosci."},{"key":"2302_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tins.2022.03.002","volume":"45","author":"Y Dong","year":"2022","unstructured":"Dong, Y. & Yong, V. W. Oxidized phospholipids as novel mediators of neurodegeneration. Trends Neurosci. 45, 419\u2013429 (2022).","journal-title":"Trends Neurosci."},{"key":"2302_CR31","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s43587-022-00205-z","volume":"2","author":"Y Dong","year":"2022","unstructured":"Dong, Y. et al. Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging. Nat. Aging 2, 508\u2013525 (2022).","journal-title":"Nat. Aging"},{"key":"2302_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.bbamcr.2008.09.020","volume":"1793","author":"H Schulze","year":"2009","unstructured":"Schulze, H., Kolter, T. & Sandhoff, K. Principles of lysosomal membrane degradation: cellular topology and biochemistry of lysosomal lipid degradation. Biochim. Biophys. Acta 1793, 674\u2013683 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"2302_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02981-w","volume":"21","author":"JY Broos","year":"2024","unstructured":"Broos, J. Y. et al. Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?. J. Neuroinflammation 21, 21 (2024).","journal-title":"J. Neuroinflammation"},{"key":"2302_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00038","volume":"9","author":"V Chiurchi\u00f9","year":"2018","unstructured":"Chiurchi\u00f9, V., Leuti, A. & Maccarrone, M. Bioactive lipids and chronic inflammation: managing the fire within. Front. Immunol. 9, 38 (2018).","journal-title":"Front. Immunol."},{"key":"2302_CR35","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s00401-011-0882-3","volume":"122","author":"WR Yu","year":"2011","unstructured":"Yu, W. R. & Fehlings, M. G. Fas\/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application. Acta Neuropathol. 122, 747\u2013761 (2011).","journal-title":"Acta Neuropathol."},{"key":"2302_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106314","volume":"83","author":"L-Y Cui","year":"2020","unstructured":"Cui, L.-Y., Chu, S.-F. & Chen, N.-H. The role of chemokines and chemokine receptors in multiple sclerosis. Int. Immunopharmacol. 83, 106314 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"2302_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57632-w","volume":"16","author":"PS Gross","year":"2025","unstructured":"Gross, P. S. et al. Senescent-like microglia limit remyelination through the senescence associated secretory phenotype. Nat. Commun. 16, 2283 (2025).","journal-title":"Nat. Commun."},{"key":"2302_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63371-9","volume":"16","author":"F Fagiani","year":"2025","unstructured":"Fagiani, F. et al. Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids. Nat. Commun. 16, 8477 (2025).","journal-title":"Nat. Commun."},{"key":"2302_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).","journal-title":"BMC Bioinformatics"},{"key":"2302_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010066","volume":"20","author":"MJC Van der Lienden","year":"2019","unstructured":"Van der Lienden, M. J. C., Gaspar, P., Boot, R., Aerts, J. M. F. G. & Van Eijk, M. Glycoprotein non-metastatic protein B: an emerging biomarker for lysosomal dysfunction in macrophages. Int. J. Mol. Sci. 20, 66 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2302_CR41","doi-asserted-by":"publisher","unstructured":"Tejwani, L. et al. Lysosomes cell autonomously regulate myeloid cell states and immune responses. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.11.11.623074 (2024).","DOI":"10.1101\/2024.11.11.623074"},{"key":"2302_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49312-y","volume":"15","author":"J Beli\u00ebn","year":"2024","unstructured":"Beli\u00ebn, J. et al. CHIT1 at diagnosis predicts faster disability progression and reflects early microglial activation in multiple sclerosis. Nat. Commun. 15, 5013 (2024).","journal-title":"Nat. Commun."},{"key":"2302_CR43","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290 (2017).","journal-title":"Cell"},{"key":"2302_CR44","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/bioinformatics\/bty926","volume":"35","author":"GJ Hunt","year":"2019","unstructured":"Hunt, G. J., Freytag, S., Bahlo, M. & Gagnon-Bartsch, J. A. dtangle: accurate and robust cell type deconvolution. Bioinformatics 35, 2093\u20132099 (2019).","journal-title":"Bioinformatics"},{"key":"2302_CR45","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli, R. C. et al. Microglia states and nomenclature: a field at its crossroads. Neuron 110, 3458\u20133483 (2022).","journal-title":"Neuron"},{"key":"2302_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-021-02263-w","volume":"141","author":"E Gerrits","year":"2021","unstructured":"Gerrits, E. et al. Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer\u2019s disease. Acta Neuropathol. 141, 681\u2013696 (2021).","journal-title":"Acta Neuropathol."},{"key":"2302_CR47","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41586-024-07871-6","volume":"633","author":"GS Green","year":"2024","unstructured":"Green, G. S. et al. Cellular communities reveal trajectories of brain ageing and Alzheimer\u2019s disease. Nature 633, 634\u2013645 (2024).","journal-title":"Nature"},{"key":"2302_CR48","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","volume":"178","author":"DA Jaitin","year":"2019","unstructured":"Jaitin, D. A. et al. Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner. Cell 178, 686\u2013698 (2019).","journal-title":"Cell"},{"key":"2302_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01010-8","volume":"8","author":"C B\u00f6ttcher","year":"2020","unstructured":"B\u00f6ttcher, C. et al. Single-cell mass cytometry reveals complex myeloid cell composition in active lesions of progressive multiple sclerosis. Acta Neuropathol. Commun. 8, 136 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"2302_CR50","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.cmet.2013.11.001","volume":"18","author":"X Xu","year":"2013","unstructured":"Xu, X. et al. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 18, 816\u2013830 (2013).","journal-title":"Cell Metab."},{"key":"2302_CR51","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1161\/CIRCRESAHA.118.312804","volume":"123","author":"K Kim","year":"2018","unstructured":"Kim, K. et al. Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models. Circ. Res. 123, 1127\u20131142 (2018).","journal-title":"Circ. Res."},{"key":"2302_CR52","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/s41593-024-01765-6","volume":"27","author":"AM Alsema","year":"2024","unstructured":"Alsema, A. M. et al. Spatially resolved gene signatures of white matter lesion progression in multiple sclerosis. Nat. Neurosci. 27, 2341\u20132353 (2024).","journal-title":"Nat. Neurosci."},{"key":"2302_CR53","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20178124","volume":"14","author":"R Argelaguet","year":"2018","unstructured":"Argelaguet, R. et al. Multi-omics factor analysis\u2014a framework for unsupervised integration of multi-omics data sets. Mol. Syst. Biol. 14, e8124 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"2302_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).","journal-title":"BMC Genomics"},{"key":"2302_CR55","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1021\/acs.accounts.2c00521","volume":"55","author":"JM Punt","year":"2022","unstructured":"Punt, J. M., van der Vliet, D. & van der Stelt, M. Chemical probes to control and visualize lipid metabolism in the brain. Acc. Chem. Res. 55, 3205\u20133217 (2022).","journal-title":"Acc. Chem. Res."},{"key":"2302_CR56","doi-asserted-by":"publisher","first-page":"14694","DOI":"10.1073\/pnas.96.26.14694","volume":"96","author":"Y Liu","year":"1999","unstructured":"Liu, Y., Patricelli, M. P. & Cravatt, B. F. Activity-based protein profiling: the serine hydrolases. Proc. Natl Acad. Sci. USA 96, 14694\u201314699 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2302_CR57","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/nprot.2017.159","volume":"13","author":"EJ Van Rooden","year":"2018","unstructured":"Van Rooden, E. J. et al. Mapping in vivo target interaction profiles of covalent inhibitors using chemical proteomics with label-free quantification. Nat. Protoc. 13, 752\u2013767 (2018).","journal-title":"Nat. Protoc."},{"key":"2302_CR58","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aaf7497","volume":"356","author":"ACM Van Esbroeck","year":"2017","unstructured":"Van Esbroeck, A. C. M. et al. Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474. Science 356, 1084\u20131087 (2017).","journal-title":"Science"},{"key":"2302_CR59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrd3620","volume":"11","author":"DA Bachovchin","year":"2012","unstructured":"Bachovchin, D. A. & Cravatt, B. F. The pharmacological landscape and therapeutic potential of serine hydrolases. Nat. Rev. Drug Discov. 11, 52\u201368 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2302_CR60","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.1174447","volume":"325","author":"M Sardiello","year":"2009","unstructured":"Sardiello, M. et al. A gene network regulating lysosomal biogenesis and function. Science 325, 473\u2013477 (2009).","journal-title":"Science"},{"key":"2302_CR61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/med.21597","volume":"40","author":"F Huang","year":"2020","unstructured":"Huang, F., Wang, K. & Shen, J. Lipoprotein-associated phospholipase A2: the story continues. Med. Res. Rev. 40, 79\u2013134 (2020).","journal-title":"Med. Res. Rev."},{"key":"2302_CR62","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/s42255-024-01003-0","volume":"6","author":"AK Sharma","year":"2024","unstructured":"Sharma, A. K., Khandelwal, R. & Wolfrum, C. Futile lipid cycling: from biochemistry to physiology. Nat. Metab. 6, 808\u2013824 (2024).","journal-title":"Nat. Metab."},{"key":"2302_CR63","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1126\/science.1209200","volume":"334","author":"DK Nomura","year":"2011","unstructured":"Nomura, D. K. et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334, 809\u2013813 (2011).","journal-title":"Science"},{"key":"2302_CR64","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1021\/acschemneuro.5c00638","volume":"16","author":"D Van der Vliet","year":"2025","unstructured":"Van der Vliet, D. et al. Spatially resolved mapping of monoacylglycerol lipase activity in the brain. ACS Chem. Neurosci. 16, 4622\u20134635 (2025).","journal-title":"ACS Chem. Neurosci."},{"key":"2302_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268590","volume":"17","author":"AM Kemble","year":"2022","unstructured":"Kemble, A. M. et al. A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature. PLoS ONE 17, e0268590 (2022).","journal-title":"PLoS ONE"},{"key":"2302_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39447-9","volume":"14","author":"P Androvic","year":"2023","unstructured":"Androvic, P. et al. Spatial transcriptomics-correlated electron microscopy maps transcriptional and ultrastructural responses to brain injury. Nat. Commun. 14, 4115 (2023).","journal-title":"Nat. Commun."},{"key":"2302_CR67","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210227","volume":"218","author":"G Gouna","year":"2021","unstructured":"Gouna, G. et al. TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination. J. Exp. Med. 218, e20210227 (2021).","journal-title":"J. Exp. Med."},{"key":"2302_CR68","doi-asserted-by":"publisher","first-page":"e533","DOI":"10.1212\/WNL.0000000000207459","volume":"101","author":"JY Broos","year":"2023","unstructured":"Broos, J. Y. et al. Association of arachidonic acid-derived lipid mediators with disease severity in patients with relapsing and progressive multiple sclerosis. Neurology 101, e533\u2013e545 (2023).","journal-title":"Neurology"},{"key":"2302_CR69","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/WCO.0000000000000818","volume":"33","author":"M Absinta","year":"2020","unstructured":"Absinta, M., Lassmann, H. & Trapp, B. D. Mechanisms underlying progression in multiple sclerosis. Curr. Opin. Neurol. 33, 277\u2013285 (2020).","journal-title":"Curr. Opin. Neurol."},{"key":"2302_CR70","doi-asserted-by":"publisher","first-page":"104465","DOI":"10.1016\/j.ebiom.2023.104465","volume":"89","author":"L Bogers","year":"2023","unstructured":"Bogers, L. et al. Selective emergence of antibody-secreting cells in the multiple sclerosis brain. eBioMedicine 89, 104465 (2023).","journal-title":"eBioMedicine"},{"key":"2302_CR71","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","volume":"10","author":"I Sanz","year":"2019","unstructured":"Sanz, I. et al. Challenges and opportunities for consistent classification of human B cell and plasma cell populations. Front. Immunol. 10, 2458 (2019).","journal-title":"Front. Immunol."},{"key":"2302_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104701","volume":"94","author":"P Maggi","year":"2023","unstructured":"Maggi, P. et al. B cell depletion therapy does not resolve chronic active multiple sclerosis lesions. eBioMedicine 94, 104701 (2023).","journal-title":"eBioMedicine"},{"key":"2302_CR73","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s40263-022-00951-z","volume":"36","author":"A Geladaris","year":"2022","unstructured":"Geladaris, A., Torke, S. & Weber, M. S. Bruton\u2019s tyrosine kinase inhibitors in multiple sclerosis: pioneering the path towards treatment of progression?. CNS Drugs 36, 1019\u20131030 (2022).","journal-title":"CNS Drugs"},{"key":"2302_CR74","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa2415988","volume":"392","author":"RJ Fox","year":"2025","unstructured":"Fox, R. J. et al. Tolebrutinib in nonrelapsing secondary progressive multiple sclerosis. N. Engl. J. Med. 392, 1883\u20131892 (2025).","journal-title":"N. Engl. J. Med."},{"key":"2302_CR75","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","volume":"14","author":"JL Blankman","year":"2007","unstructured":"Blankman, J. L., Simon, G. M. & Cravatt, B. F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem. Biol. 14, 1347\u20131356 (2007).","journal-title":"Chem. Biol."},{"key":"2302_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8216","volume":"6","author":"JB Hernandez","year":"2015","unstructured":"Hernandez, J. B. et al. The CREB\/CRTC2 pathway modulates autoimmune disease by promoting Th17 differentiation. Nat. Commun. 6, 7216 (2015).","journal-title":"Nat. Commun."},{"key":"2302_CR77","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.celrep.2012.05.001","volume":"1","author":"JR Piro","year":"2012","unstructured":"Piro, J. R. et al. A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer\u2019s disease. Cell Rep. 1, 617\u2013623 (2012).","journal-title":"Cell Rep."},{"key":"2302_CR78","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.4049\/jimmunol.1700503","volume":"201","author":"N Kim","year":"2018","unstructured":"Kim, N. et al. Lipoxin B4 enhances human memory B cell antibody production via upregulating cyclooxygenase-2 expression. J. Immunol. 201, 3343\u20133351 (2018).","journal-title":"J. Immunol."},{"key":"2302_CR79","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.4049\/jimmunol.1103483","volume":"189","author":"S Ramon","year":"2012","unstructured":"Ramon, S., Gao, F., Serhan, C. N. & Phipps, R. P. Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J. Immunol. 189, 1036\u20131042 (2012).","journal-title":"J. Immunol."},{"key":"2302_CR80","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.4049\/jimmunol.174.5.2619","volume":"174","author":"EP Ryan","year":"2005","unstructured":"Ryan, E. P. et al. Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J. Immunol. 174, 2619\u20132626 (2005).","journal-title":"J. Immunol."},{"key":"2302_CR81","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00005373-199610000-00004","volume":"41","author":"H Yamamoto","year":"1996","unstructured":"Yamamoto, H., Siltharm, S., deSerres, S., Hultman, C. S. & Meyer, A. A. Effect of cyclo-oxygenase inhibition on in vitro B-cell function after burn injury. J. Trauma 41, 620\u2013621 (1996).","journal-title":"J. Trauma"},{"key":"2302_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2018.05.002","volume":"71","author":"MP Baggelaar","year":"2018","unstructured":"Baggelaar, M. P., Maccarrone, M. & van der Stelt, M. 2-Arachidonoylglycerol: a signaling lipid with manifold actions in the brain. Prog. Lipid Res. 71, 1\u201317 (2018).","journal-title":"Prog. Lipid Res."},{"key":"2302_CR83","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","volume":"75","author":"M Maccarrone","year":"2023","unstructured":"Maccarrone, M. et al. Goods and bads of endocannabinoid system as a therapeutic target: lessons learned after 30 years. Pharmacol. Rev. 75, 885\u2013958 (2023).","journal-title":"Pharmacol. Rev."},{"key":"2302_CR84","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1088208","volume":"302","author":"G Marsicano","year":"2003","unstructured":"Marsicano, G. et al. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84\u201388 (2003).","journal-title":"Science"},{"key":"2302_CR85","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nm.f.1869","volume":"14","author":"I Katona","year":"2008","unstructured":"Katona, I. & Freund, T. F. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat. Med. 14, 923\u2013930 (2008).","journal-title":"Nat. Med."},{"key":"2302_CR86","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nm1561","volume":"13","author":"K Maresz","year":"2007","unstructured":"Maresz, K. et al. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat. Med. 13, 492\u2013497 (2007).","journal-title":"Nat. Med."},{"key":"2302_CR87","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbi.2018.12.013","volume":"77","author":"M Mecha","year":"2019","unstructured":"Mecha, M. et al. The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia. Brain Behav. Immun. 77, 110\u2013126 (2019).","journal-title":"Brain Behav. Immun."},{"key":"2302_CR88","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","volume":"49","author":"M Mecha","year":"2015","unstructured":"Mecha, M. et al. Endocannabinoids drive the acquisition of an alternative phenotype in microglia. Brain Behav. Immun. 49, 233\u2013245 (2015).","journal-title":"Brain Behav. Immun."},{"key":"2302_CR89","doi-asserted-by":"publisher","first-page":"13765","DOI":"10.1002\/anie.201407807","volume":"53","author":"G Hern\u00e1ndez-Torres","year":"2014","unstructured":"Hern\u00e1ndez-Torres, G. et al. A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis. Angew. Chem. Int. Ed. Engl. 53, 13765\u201313770 (2014).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2302_CR90","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/glia.22742","volume":"63","author":"A Bernal-Chico","year":"2015","unstructured":"Bernal-Chico, A. et al. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo: MAGL blockade protects oligodendrocytes and myelin. Glia 63, 163\u2013176 (2015).","journal-title":"Glia"},{"key":"2302_CR91","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1021\/acs.jmedchem.5b01812","volume":"59","author":"M Brindisi","year":"2016","unstructured":"Brindisi, M. et al. Development and pharmacological characterization of selective blockers of 2-arachidonoyl glycerol degradation with efficacy in rodent models of multiple sclerosis and pain. J. Med. Chem. 59, 2612\u20132632 (2016).","journal-title":"J. Med. Chem."},{"key":"2302_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.109940","volume":"252","author":"L Guadalupi","year":"2024","unstructured":"Guadalupi, L. et al. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis. Neuropharmacology 252, 109940 (2024).","journal-title":"Neuropharmacology"},{"key":"2302_CR93","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pneurobio.2017.10.007","volume":"160","author":"V Chiurchi\u00f9","year":"2018","unstructured":"Chiurchi\u00f9, V., van der Stelt, M., Centonze, D. & Maccarrone, M. The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: clues for other neuroinflammatory diseases. Prog. Neurobiol. 160, 82\u2013100 (2018).","journal-title":"Prog. Neurobiol."},{"key":"2302_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"2302_CR95","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1093\/brain\/awae414","volume":"148","author":"JQA Chen","year":"2024","unstructured":"Chen, J. Q. A. et al. Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis. Brain 148, 2201\u20132217 (2024).","journal-title":"Brain"},{"key":"2302_CR96","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2302_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"2302_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"2302_CR99","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"2302_CR100","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1021\/acs.jproteome.0c00310","volume":"19","author":"T Zhang","year":"2020","unstructured":"Zhang, T. et al. Block design with common reference samples enables robust large-scale label-free quantitative proteome profiling. J. Proteome Res. 19, 2863\u20132872 (2020).","journal-title":"J. Proteome Res."},{"key":"2302_CR101","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."},{"key":"2302_CR102","doi-asserted-by":"publisher","unstructured":"Van der Vliet, D. Foamy microglia link oxylipins to disease progression in multiple sclerosis. Zenodo https:\/\/doi.org\/10.5281\/zenodo.17735822 (2026).","DOI":"10.5281\/zenodo.17735822"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02302-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T19:02:06Z","timestamp":1783364526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-026-02302-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":102,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2302"],"URL":"https:\/\/doi.org\/10.1038\/s41593-026-02302-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.18.619040","asserted-by":"object"}]},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.C.-B., A.P., W.M., U.G. and L.C. are employees of F. Hoffmann-La Roche, which holds patents on inhibitors of MAGL. M.v.d.S. is an author on patents describing inhibitors of MAGL. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}